Iodixanol: Risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations

被引:16
|
作者
Cheruvu, Bharadwaj [1 ]
Henning, Kathleen [1 ]
Mulligan, Janine [1 ]
Klippenstein, Donald [1 ]
Lawrence, David [1 ]
Gurtoo, Lalit [1 ]
Gottlieb, Ronald H. [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
computed tomography; contrast-induced nephropathy;
D O I
10.1097/rct.0b013e31802e29d9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To assess the risk of contrast-induced nephropathy in cancer patients with underlying renal insufficiency receiving the iso-osmolar intravenous contrast agent iodixanol for diagnostic computed tomography (CT) examinations. Methods: Institutional review board approval was obtained with waiver of informed consent. Our study was a retrospective evaluation comparing the incidence of contrast-induced nephropathy in consecutive patients with underlying renal insufficiency undergoing diagnostic CT examinations receiving iodixanol from November 2003 to June 2005 with a comparison group of patients with normal baseline renal function over the same period. Renal insufficiency was considered a serum creatinine level more than 1.2 mg/dL in females and more than 1.5 mg/dL in males. Contrast nephropathy was considered an absolute elevation of 0.5 mg/dL or 25% elevation in serum creatinine level. Results: In the group of patients receiving iodixanol with underlying renal insufficiency (189 patients), 9.0% developed contrast nephropathy (P = 0.015) with 4.8% of patients developing irreversible renal damage (P = 0.03). This compared with 4.9% of patients receiving iodixanol (185 patients) and 3.1% of patients receiving iohexol (194 patients) with normal baseline renal function developing contrast nephropathy (P = 0.38) with 3.2% of the iodixanol patients and 1.0% of the iohexol patients developing irreversible renal damage (P = 0.13). Conclusions: The risk of contrast-induced nephropathy is significantly higher in patients with underlying renal insufficiency receiving iodixanol than that for patients with normal baseline renal function, but this should not serve as an absolute contraindication for these patients to receive intravenous iodinated contrast for diagnostic CT examinations particularly in patients with life-threatening clinical questions in which contrasted CT may provide valuable information.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 31 条
  • [21] Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography
    Filiopoulos, Vassilis
    Biblaki, Dimitra
    Lazarou, Dimitrios
    Chrisis, Dimitrios
    Fatourou, Mavra
    Lafoyianni, Sofia
    Vlassopoulos, Dimosthenis
    CLINICAL KIDNEY JOURNAL, 2013, 6 (06) : 578 - 583
  • [22] Effect of Dongchongxiacao (Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography
    Zhao Kai
    Li Yongjian
    Gao Sheng
    Lin Yu
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2015, 35 (04) : 422 - 427
  • [23] Effect of Dongchongxiacao(Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography
    Zhao Kai
    Li Yongjian
    Gao Sheng
    Lin Yu
    Journal of Traditional Chinese Medicine, 2015, 35 (04) : 422 - 427
  • [24] Estimating risk of exposure induced cancer death in patients undergoing computed tomography pulmonary angiography
    Karimizarchi, H.
    Chaparian, A.
    RADIOPROTECTION, 2017, 52 (02) : 81 - 86
  • [25] Effect of an Electronic Alert on Risk of Contrast-Induced Acute Kidney Injury in Hospitalized Patients Undergoing Computed Tomography
    Cho, AJin
    Lee, Jung Eun
    Yoon, Jae Young
    Jang, Hye Ryoun
    Huh, Wooseong
    Kim, Yoon-Goo
    Kim, Dae Joong
    Oh, Ha Young
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (01) : 74 - 81
  • [26] Artificial Intelligence Algorithm-Based Computed Tomography Image in Assessment of Acute Renal Insufficiency of Patients Undergoing Percutaneous Coronary Intervention
    Zhang, Xiuming
    Liu, Tao
    Tian, Chunhua
    CONTRAST MEDIA & MOLECULAR IMAGING, 2022, 2022
  • [27] Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty A systematic review and meta-analysis (PRISMA)
    Behzadi, Ashkan Heshmatzadeh
    Amoozgar, Behzad
    Jain, Shalini
    Velasco, Noel
    Zahid, Umar
    Abbasi, Hamidreza
    Alasadi, Lutfi
    Prince, Martin R.
    MEDICINE, 2021, 100 (10) : E24603
  • [28] Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention
    Chong, E.
    Shen, L.
    Poh, K. K.
    Tan, H. C.
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (03) : 164 - 169
  • [29] A head-to-head comparison of homocysteine and cystatin C as pre-procedure predictors for contrast-induced nephropathy in patients undergoing coronary computed tomography angiography
    Li, Suhua
    Tang, Xixiang
    Peng, Long
    Luo, Yanting
    Zhao, Yunyue
    Chen, Lin
    Dong, Ruimin
    Zhu, Jieming
    Chen, Yanming
    Liu, Jinlai
    CLINICA CHIMICA ACTA, 2015, 444 : 86 - 91
  • [30] Remote Ischemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate Renal Impairment Undergoing Percutaneous Coronary Angiography: A Meta-Analysis
    Deng, Jin
    Lu, Yi
    Ou, Jihong
    Shao, Xiaofei
    Wang, Xin
    Xie, Hongping
    KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (04) : 549 - 564